Latest Parkin Stories
Rapamycin, a drug used to prevent rejection in transplants, could delay the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's.
Using a two-photon microscope capable of peering deep within living tissue, researchers at the University of California, San Diego School of Medicine have found new evidence that alpha-synuclein protein build-up inside neurons causes them to not only become "leaky," but also to misfire due to calcium fluxes.
Researchers have taken a step toward personalized medicine for Parkinson's disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatments.
Van Andel Institute announces that researchers at Lund University in Sweden have published a study detailing how Parkinson's disease spreads through the brain.
An international team led by human genetic researchers at the University of British Columbia and Vancouver Coastal Health has identified the latest gene associated with typical late-onset Lewy body Parkinson's disease (PD), with the help of a Canadian Mennonite family of Dutch-German-Russian ancestry.
Long-term aim is to develop new treatments to block the spread of damaged proteins in the brain.
Researchers at the University of Toronto Scarborough (UTSC) used an innovative technique to examine chemical interactions that are implicated in Parkinson's Disease.
Mutations in the LRRK2 gene are the most common cause of genetic Parkinson's disease (PD).
Though there is no known cure for Parkinson’s disease, there are means to control the symptoms. Researchers at UCLA may have found a way to determine which patients will experience a more rapid decline in motor function, which is potentially beneficial in developing new therapies and identifying who can benefit the most from early intervention.
- A serpent whose bite was fabled to produce intense thirst.